$879 Million is the total value of Vivo Capital, LLC's 49 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 110.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | Zymeworks Inch5861p103 | $600,219,000 | – | 82,834,668 | +100.0% | 68.30% | – | |
| New | Zai Lab Limited98887q104 | $207,939,000 | – | 2,552,237 | +100.0% | 23.66% | – | |
| New | Sinovac Biotech Ltd.p8696w104 | $48,250,000 | – | 9,610,156 | +100.0% | 5.49% | – | |
| New | Verona Pharma PLC925050106 | $22,411,000 | – | 2,805,035 | +100.0% | 2.55% | – | |
| New | Soleno Therapeutics, Inc. - Warrant834203135 | $9,000 | – | 188,772 | +100.0% | 0.00% | – | |
| SLNOW | Exit | Soleno Therapeutics, Inc. - Warrantwarrant | $0 | – | -188,772 | -100.0% | -0.00% | – |
| BPMX | Exit | BioPharmX Corporation | $0 | – | -317,270 | -100.0% | -0.02% | – |
| AKTX | Exit | Akari Therapeutics Plcadr | $0 | – | -345,850 | -100.0% | -0.07% | – |
| SELB | Exit | Selecta Biosciences Inc | $0 | – | -546,054 | -100.0% | -0.09% | – |
| SRRA | Exit | Sierra Oncology, Inc | $0 | – | -2,438,270 | -100.0% | -0.13% | – |
| AGRX | Exit | Agile Therapeutics, Inc. | $0 | – | -1,513,975 | -100.0% | -0.21% | – |
| DBVT | Exit | DBV Technologies S.A.adr | $0 | – | -269,995 | -100.0% | -0.21% | – |
| GNCA | Exit | Genocea Biosciences Inc | $0 | – | -626,401 | -100.0% | -0.23% | – |
| ACRS | Exit | Aclaris Therapeutics, Inc. | $0 | – | -1,647,214 | -100.0% | -0.34% | – |
| DTIL | Exit | Precision Biosciences Inc | $0 | – | -280,511 | -100.0% | -0.35% | – |
| ZGNX | Exit | Zogenix Inc | $0 | – | -105,000 | -100.0% | -0.47% | – |
| MTNB | Exit | Matinas Biopharma Hldgs Inc | $0 | – | -6,818,181 | -100.0% | -0.55% | – |
| KRTX | Exit | Karuna Therapeutics Inc | $0 | – | -325,000 | -100.0% | -0.61% | – |
| KALA | Exit | Kala Pharmaceuticals, Inc. | $0 | – | -1,043,020 | -100.0% | -0.62% | – |
| DERM | Exit | Dermira Inc | $0 | – | -700,000 | -100.0% | -0.63% | – |
| GLMD | Exit | Galmed Pharmaceuticals Ltd | $0 | – | -971,337 | -100.0% | -0.67% | – |
| VRNA | Exit | Verona Pharma PLCads | $0 | – | -1,492,951 | -100.0% | -0.71% | – |
| APLS | Exit | Apellis Pharmaceuticals, Inc. | $0 | – | -383,538 | -100.0% | -0.91% | – |
| Exit | Nabriva Therapeutics AG | $0 | – | -4,039,139 | -100.0% | -0.92% | – | |
| OBSV | Exit | Obseva SA | $0 | – | -937,147 | -100.0% | -0.99% | – |
| KNSA | Exit | Kiniksa Pharmaceuticals | $0 | – | -843,478 | -100.0% | -1.07% | – |
| RCKT | Exit | Rocket Pharmaceuticals Inc | $0 | – | -786,712 | -100.0% | -1.11% | – |
| SLNO | Exit | Soleno Therapeutics, Inc. | $0 | – | -4,268,959 | -100.0% | -1.12% | – |
| AUPH | Exit | Aurinia Pharmaceuticals Inc. | $0 | – | -1,913,623 | -100.0% | -1.18% | – |
| XENE | Exit | Xenon Pharmaceuticals Inc | $0 | – | -1,405,476 | -100.0% | -1.30% | – |
| MEIP | Exit | MEI Pharma Inc | $0 | – | -5,681,397 | -100.0% | -1.33% | – |
| CBAY | Exit | Cymabay Therapeutics Inc | $0 | – | -2,154,934 | -100.0% | -1.45% | – |
| CHMA | Exit | Chiasma Inc | $0 | – | -2,377,213 | -100.0% | -1.66% | – |
| ORTX | Exit | Orchard Therapeutics plcads | $0 | – | -1,312,084 | -100.0% | -1.72% | – |
| EIGR | Exit | Eiger BioPharmaceuticals Inc | $0 | – | -1,791,257 | -100.0% | -1.78% | – |
| FIXX | Exit | Homology Medicines, Inc. | $0 | – | -1,159,742 | -100.0% | -2.13% | – |
| AMRS | Exit | Amyris, Inc | $0 | – | -6,490,557 | -100.0% | -2.16% | – |
| MRTX | Exit | Mirati Therapeutics Inc. | $0 | – | -233,045 | -100.0% | -2.25% | – |
| MNLO | Exit | Menlo Therapeutics Inc. | $0 | – | -4,011,236 | -100.0% | -2.25% | – |
| MDCO | Exit | The Medicines Company | $0 | – | -669,012 | -100.0% | -2.29% | – |
| KDMN | Exit | Kadmon Holdings Inc | $0 | – | -12,606,605 | -100.0% | -2.43% | – |
| KALV | Exit | KalVista Pharmaceuticals Inc. | $0 | – | -1,359,149 | -100.0% | -2.82% | – |
| ZYME | Exit | Zymeworks Inc | $0 | – | -1,453,467 | -100.0% | -3.00% | – |
| SVA | Exit | Sinovac Biotech Ltd. | $0 | – | -5,900,000 | -100.0% | -3.58% | – |
| IOVA | Exit | Iovance Biotherapeutics, Inc. | $0 | – | -1,600,000 | -100.0% | -3.68% | – |
| INSM | Exit | Insmed Inc | $0 | – | -1,748,174 | -100.0% | -4.19% | – |
| CDXS | Exit | Codexis, Inc | $0 | – | -2,614,458 | -100.0% | -4.52% | – |
| TCDA | Exit | Tricida, Inc. | $0 | – | -1,424,525 | -100.0% | -5.27% | – |
| ARWR | Exit | Arrowhead Pharmaceuticals Inc | $0 | – | -2,765,153 | -100.0% | -6.87% | – |
| CRNX | Exit | Crinetics Pharmaceuticals Inc | $0 | – | -3,375,169 | -100.0% | -7.91% | – |
| ASND | Exit | Ascendis Pharma A/Sadr | $0 | – | -2,060,135 | -100.0% | -22.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| CODEXIS INC | 29 | Q3 2023 | 8.0% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
| Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
| Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.